Philip Rümke

978 total citations
22 papers, 752 citations indexed

About

Philip Rümke is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Philip Rümke has authored 22 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Philip Rümke's work include Immunotherapy and Immune Responses (11 papers), Cutaneous Melanoma Detection and Management (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Philip Rümke is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Cutaneous Melanoma Detection and Management (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Philip Rümke collaborates with scholars based in Netherlands, Belgium and United States. Philip Rümke's co-authors include J E de Vries, Annemarie Hekman, Santoso Cornain, J. Bernheim, Dirk J. Ruiter, Arie C. Voordouw, Hergen Spits, Carl G. Figdor, Gerrit D. Keizer and Anje A. te Velde and has published in prestigious journals such as Cancer, Annals of the New York Academy of Sciences and International Journal of Cancer.

In The Last Decade

Philip Rümke

22 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Rümke Netherlands 15 389 217 189 146 109 22 752
Rikiya Tsunoda Japan 16 406 1.0× 159 0.7× 252 1.3× 34 0.2× 25 0.2× 40 783
S Nishikawa Japan 9 476 1.2× 179 0.8× 341 1.8× 30 0.2× 33 0.3× 13 970
J Bradshaw United States 8 970 2.5× 248 1.1× 149 0.8× 105 0.7× 17 0.2× 8 1.2k
S E Christmas United Kingdom 14 422 1.1× 106 0.5× 126 0.7× 27 0.2× 76 0.7× 32 708
André Darveau Canada 17 267 0.7× 88 0.4× 540 2.9× 47 0.3× 19 0.2× 24 953
Sam J. P. Gobin Netherlands 18 1.2k 3.1× 243 1.1× 300 1.6× 26 0.2× 76 0.7× 25 1.5k
R Brew United Kingdom 10 303 0.8× 224 1.0× 155 0.8× 19 0.1× 40 0.4× 16 579
Mohey Eldin El Shikh United States 15 484 1.2× 117 0.5× 174 0.9× 77 0.5× 13 0.1× 24 767
A. G. Siccardi Italy 15 139 0.4× 122 0.6× 282 1.5× 348 2.4× 9 0.1× 36 827
B Dyer United States 5 337 0.9× 156 0.7× 140 0.7× 27 0.2× 10 0.1× 7 604

Countries citing papers authored by Philip Rümke

Since Specialization
Citations

This map shows the geographic impact of Philip Rümke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Rümke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Rümke more than expected).

Fields of papers citing papers by Philip Rümke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Rümke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Rümke. The network helps show where Philip Rümke may publish in the future.

Co-authorship network of co-authors of Philip Rümke

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Rümke. A scholar is included among the top collaborators of Philip Rümke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Rümke. Philip Rümke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carrel, S, Jean‐François Doré, Dirk J. Ruiter, et al.. (1991). The eortc melanoma group exchange program: Evaluation of a multicenter monoclonal antibody study. International Journal of Cancer. 48(6). 836–847. 39 indexed citations
3.
Rümke, Philip. (1990). Chemotherapy and new treatments. Current Opinion in Oncology. 2(2). 397–406. 2 indexed citations
4.
Rümke, Philip. (1990). Therapy of Advanced Melanoma. KARGER eBooks. 7 indexed citations
5.
Zandwijk, Nico van, et al.. (1990). Aerosol application of interferon-alpha in the treatment of bronchioloalveolar carcinoma. European Journal of Cancer and Clinical Oncology. 26(6). 738–740. 22 indexed citations
6.
Vries, J E de, Gerrit D. Keizer, Anje A. te Velde, et al.. (1986). Characterization of melanoma‐associated surface antigens involved in the adhesion and motility of human melanoma cells. International Journal of Cancer. 38(4). 465–473. 78 indexed citations
7.
Dewit, L., Harry Bartelink, & Philip Rümke. (1985). Concurrent cis-diamminedichloroplatinum(II) and radiation treatment for melanoma metastases: A pilot study. Radiotherapy and Oncology. 3(4). 303–309. 16 indexed citations
8.
Rümke, Philip, et al.. (1984). Prognosis of fertility in women with unexplained infertility and sperm agglutinins in the serum. Fertility and Sterility. 42(4). 561–567. 13 indexed citations
9.
Duinen, Sjoerd G. van, Dirk J. Ruiter, Philomena Hageman, et al.. (1984). Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma. Cancer. 53(7). 1566–1573. 58 indexed citations
10.
Robert-Guroff, Marjorie, et al.. (1984). Prevalence of HTLV-specific antibodies in Surinam emigrants to the Netherlands. Leukemia Research. 8(3). 501–504. 10 indexed citations
11.
Vyth‐Dreese, Florry A., Philip Rümke, Marjorie Robert‐Guroff, Gerda de Lange, & Robert C. Gallo. (1983). Antibodies against human T‐cell leukemia/lymphoma virus (HTLV) and expression of HTLV p19 antigen in relatives of a T‐cell leukemia patient originating from Surinam. International Journal of Cancer. 32(3). 337–342. 19 indexed citations
12.
Rümke, Philip, et al.. (1983). EORTC phase II trial of vindesine in advanced melanoma. European Journal of Cancer and Clinical Oncology. 19(8). 1173–1174. 3 indexed citations
13.
Es, A. van, et al.. (1982). Monkey (Macaca speciosa) antisera against melanoma. Cancer Immunology Immunotherapy. 12(2). 153–158. 1 indexed citations
14.
Cochran, A. J., et al.. (1981). Adjuvant reactivity predicts survival in patients with “high‐risk” primary malignant melanoma treated with systemic BCG. International Journal of Cancer. 28(5). 543–550. 5 indexed citations
15.
Vries, J E de & Philip Rümke. (1976). Tumour‐associated lymphocyte cytotoxicity superimposed on “Spontaneous” cytotoxicity in melanoma patients. International Journal of Cancer. 17(2). 182–190. 22 indexed citations
16.
Cornain, Santoso, et al.. (1975). Antibodies and antigen expression in human melanoma detected by the immune adherence test. International Journal of Cancer. 16(6). 981–997. 40 indexed citations
17.
Vries, J E de, Philip Rümke, & J. Bernheim. (1972). Cytotoxic lymphocytes in melanoma patients. International Journal of Cancer. 9(3). 567–576. 81 indexed citations
18.
Hekman, Annemarie & Philip Rümke. (1969). The Antigens of Human Seminal Plasma. Fertility and Sterility. 20(2). 312–323. 93 indexed citations
19.
Feltkamp, T. E. W., et al.. (1965). AUTOSPERMAGGLUTININS: IMMUNOFLUORESCENT STUDIES. Annals of the New York Academy of Sciences. 124(2). 702–708. 35 indexed citations
20.
Rümke, Philip. (1965). AUTOSPERMAGGLUTININS: A CAUSE OF INFERTILITY IN MEN. Annals of the New York Academy of Sciences. 124(2). 696–701. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rikiya Tsunoda Breakdown of academic impact, for papers by S Nishikawa Breakdown of academic impact, for papers by J Bradshaw Breakdown of academic impact, for papers by S E Christmas Breakdown of academic impact, for papers by André Darveau Breakdown of academic impact, for papers by Sam J. P. Gobin Breakdown of academic impact, for papers by R Brew Breakdown of academic impact, for papers by Mohey Eldin El Shikh Breakdown of academic impact, for papers by A. G. Siccardi Breakdown of academic impact, for papers by B Dyer
Rankless by CCL
2026